Cell Factors™
Peptide Capsules
Verified Quality

Cell Factors™

4.88 (34 Reviews)
Ships worldwide
$899.00

Sales Tax included at checkout

Laboratory Research Chemical • Scroll down for full specifications

1

Priority Shipping

Fast & Discreet

99% Purity

HPLC Verified

Full Refund

60-Day Promise

Lab Synthesis

GMP Certified

Product Information

Detailed laboratory specifications, compound structure, and research applications.

Research Grade

HPLC 99%+ Purity

Verified Origin

GMP Manufactured

Cell Factors™: Cell-Free Signaling Factors for Regenerative Research

Cellular aging research increasingly points to a central problem: communication breakdown at the receptor and signaling level.

Early-stage placental cells operate with a comprehensive regenerative messaging profile — one that supports tissue repair, immune regulation, and metabolic homeostasis. Researchers studying aging and regeneration have worked to understand what drives the decline of these processes and how they might be modeled or supported in laboratory settings.

Cell Factors™ is a placental-derived regenerative secretome developed to support that line of inquiry — and one of the first research-grade cell-free cell therapy products to deliver the full signaling output of early placental lineage cells in an acellular, DNA-free formulation.

What Are Cell Factors™?

Cell Factors™ delivers a full spectrum of messaging from key placental cell populations: Wharton’s Jelly, Amniotic Fluid and Membrane, Chorion, and Umbilical Cord Blood (UCB).

The formulation is best described as a regenerative placenta-derived secretome combination delivering the full messaging benefits of young healthy cells.  This is done without the issues often encountered with other cell-based therapies, including:

  • Undesirable immune responses
  • Off-target and unexpected effects
  • Live cell handling and degradation challenges
  • Regulatory complexities tied to living cell therapies

This positions Cell Factors as a stable, research-grade tool for in vitro studies examining cell signaling, tissue recalibration, and receptor-level communication.

How It Compares to Other Regenerative Research Models

Researchers working in regenerative cell biology have historically relied on several model systems, each with limitations:

PRP (Platelet-Rich Plasma) 

Activates basic healing pathways. The effect is limited to a narrow range of signaling targets. Cell Factors™ activates additional pathways (estimated to be 4- to 5-fold more).

Wharton’s Jelly / Stem Cell Models 

Introduce living cells with regenerative potential, but formulation consistency and stability is difficult to control. Handling is complex and regulatory restrictions limit research availability.

Exosomes (Extracellular Vesicles / Exosome-Based Therapy Products) 

They focus on cell signaling rather than live cell introduction. However, they typically activate fewer than 100 cell pathways and share sourcing and degradation challenges with stem cell models.

Cell Factors

  • Lyophilized, like other common research peptides, for consistency, potency, and easy protocol integration
  • Activates 300+ targeted cell signaling pathways
  • Acellular: no live cells, immunogenicity, or disease risk  
  • Ready for immediate use
  • Designed for compatibility with existing peptide research

Research Applications

Cell Factors is being studied for its potential to support several areas of in vitro and preclinical research:

Receptor Sensitivity and Signaling

Cell Factors™ may help researchers study how placenta-derived “cell signals” can change the strength of receptor responses to other compounds over time. This can be useful in lab work looking at why cells sometimes become less responsive (tolerance/desensitization) to other molecules — or, in some cases, how signaling can be made more responsive.

Mitochondrial Function 

Build-up of reactive oxygen species (ROS)—often called “oxidative stress”—is a major focus in cellular biology research. Cell Factors™ can be used to study how mitochondria (the cell’s energy centers) communicate with the nucleus (the cell’s control center), and how those signaling links may be made more robust in experimental systems.

Tissue Microenvironment and Inflammatory Signaling 

Chronic inflammation is a well-documented barrier in tissue repair research. Cell Factors may support preclinical studies examining inflammatory regulation, including research related to:

  • Vascular health
  • Musculoskeletal tissue growth and repair
  • Renal stress and regulation
  • Neuroinflammation

Epigenetic Reprogramming Models

Because Cell Factors™ contains a broad mix of proteins and growth factors, it may be useful for research on how cells “reset” patterns of gene activity (often called epigenetic changes). In practical terms, it can help researchers explore how these signaling molecules influence older, stressed, or diseased cell types—and whether they shift key cellular markers back toward more healthy and youthful patterns in experimental models.

In Vitro Research Applications

Research Area Potential Application
Aging biology Epigenetic recalibration and cellular aging models
Regenerative medicine Tissue microenvironment signaling studies
Mitochondrial research Mitochondrial-nuclear communication pathways
Inflammation research Cytokine amplification and upstream inflammatory triggers
Receptor pharmacology Receptor sensitivity and signaling coherence models
Metabolic research Integration with peptide and hormone pathway studies

Available Research Formats

Cell Factors™ is available in three configurations to support varied research protocols:

  • Single-cycle format
  • Multi-cycle environmental recalibration programs
  • Integrated research protocol with Klotho

Research Chemical Disclaimer

This product is intended for laboratory research use only. It is not for human consumption, diagnostic, or therapeutic purposes. Handling should only be performed by qualified professionals.

Complete Your Research

Synergistic compounds from the Peptide Capsules lineup

View Full Collection
MicroFLGR (2MG)

MicroFLGR (2MG)

Product Description

Follistatin (FLGR242), is a novel fragmented, modified version of Follistatin-344 (FST-344) that does not bind to the protein activin. Activin is responsible for the negative effects of myostatin inhibition such as unwanted cellular growth in laboratory models. It also contains a patented albumin binder.

Follistatin protein (FST) fused with an albumin-binding construct that uses a hydrophilic glycine-serine linker to achieve high-affinity binding to serum albumin (<20 nM Kd). This recombinant technology allows researchers to study follistatin-albumin interactions and protein trafficking in experimental systems.

Research applications include muscle mass development studies, activin neutralization assays, and TGF-β superfamily pathway modulation with albumin binding dynamics. The construct maintains biological activity while enabling investigation of albumin as a carrier protein.

US GMP-manufactured with third-party verification and comprehensive COAs for reproducible research outcomes.

Peptide Information

Property Value
Peptide Type Follistatin-Albumin Binding Construct
Technology Albumin-binding peptide fusion (GGSGGSGGSGGRLIEDICLPRWGCLWEDD linker)
Molecular Weight ~40 kDa
Binding Affinity <20 nM
Synonyms FST-Albumin Construct, Extended Half-Life Follistatin

Lyophilized Peptides:

These peptides are freeze-dried, a process that not only extends shelf life but also preserves the purity and integrity of the peptides during storage. We do not use any fillers in this process.

Product Usage:

This PRODUCT IS INTENDED AS A RESEARCH CHEMICAL ONLY. This designation allows the use of research chemicals strictly for in vitro testing and laboratory experimentation only. All product information available on this website is for educational purposes only.  This product should only be handled by licensed, qualified professionals. This product is not a drug, food, or cosmetic and may not be misbranded, misused or mislabeled as a drug.

$15000.00

Follistatin (FLGR242) (10mg)
Options

Follistatin (FLGR242) (10mg)

Product Description

Follistatin (FLGR242), is a novel fragmented, modified version of Follistatin-344 (FST-344) that does not bind to the protein activin. Activin is responsible for the negative effects of myostatin inhibition such as unwanted cellular growth in laboratory models. It also contains a patented albumin binder.

Follistatin protein (FST) fused with an albumin-binding construct that uses a hydrophilic glycine-serine linker to achieve high-affinity binding to serum albumin (<20 nM Kd). This recombinant technology allows researchers to study follistatin-albumin interactions and protein trafficking in experimental systems.

Research applications include muscle mass development studies, activin neutralization assays, and TGF-β superfamily pathway modulation with albumin binding dynamics. The construct maintains biological activity while enabling investigation of albumin as a carrier protein.

US GMP-manufactured with third-party verification and comprehensive COAs for reproducible research outcomes.

Peptide Information

Property Value
Peptide Type Follistatin-Albumin Binding Construct
Technology Albumin-binding peptide fusion (GGSGGSGGSGGRLIEDICLPRWGCLWEDD linker)
Molecular Weight ~40 kDa
Binding Affinity <20 nM
Synonyms FST-Albumin Construct, Extended Half-Life Follistatin

Lyophilized Peptides:

These peptides are freeze-dried, a process that not only extends shelf life but also preserves the purity and integrity of the peptides during storage. We do not use any fillers in this process.

Product Usage:

This PRODUCT IS INTENDED AS A RESEARCH CHEMICAL ONLY. This designation allows the use of research chemicals strictly for in vitro testing and laboratory experimentation only. All product information available on this website is for educational purposes only.  This product should only be handled by licensed, qualified professionals. This product is not a drug, food, or cosmetic and may not be misbranded, misused or mislabeled as a drug.

$2397 – $28764

Klotho (alphaKlothoLR) (20mcg)
Options

Klotho (alphaKlothoLR) (20mcg)

Product Description

alphaKlothoLR is a patented, long-release version of the recombinant Klotho protein, which contains specific amino acid sequences, linkers, and an albumin binding group that allows for a sustained delivery of Klotho with cellular activity up to 19 days.

This research-grade construct combines α-Klotho protein with a proprietary 29-amino acid albumin binding peptide (GGSGGSGGSGGRLIEDICLPRWGCLWEDD). The modification enables strong albumin binding affinity (<20 nM) while maintaining native FGF23 binding activity (15-30 nM).

Produced through recombinant expression with rigorous third-party testing. Each batch includes HPLC and LC-MS verification to confirm molecular identity and purity standards. Complete analytical documentation supports laboratory applications investigating protein-albumin interactions, FGF23 signaling pathways, and albumin binding mechanisms.

For in vitro research use only.

Klotho Protein Information

Property Value
Peptide Sequence α-Klotho protein (1012 amino acids) + albumin binding construct: GGSGGSGGSGGRLIEDICLPRWGCLWEDD
Molecular Weight ~133-135 kDa (full construct with albumin binder)
Albumin Binding Affinity (Kd) <20 nM
FGF23 Binding Affinity (Kd) 15-30 nM (optimized: 16.2 nM)
Synonyms α-Klotho-albumin binding construct, Modified Klotho with glycine-serine linker

Lyophilized Peptides:

These peptides are freeze-dried, a process that not only extends shelf life but also preserves the purity and integrity of the peptides during storage. We do not use any fillers in this process.

Product Usage:

This PRODUCT IS INTENDED AS A RESEARCH CHEMICAL ONLY. This designation allows the use of research chemicals strictly for in vitro testing and laboratory experimentation only. All product information available on this website is for educational purposes only.  This product should only be handled by licensed, qualified professionals. This product is not a drug, food, or cosmetic and may not be misbranded, misused or mislabeled as a drug.

$2397 – $15341

Research Specification

Comprehensive documentation for laboratory application and compound verification.

HPLC Verification

Purity levels exceeding 99.2% guaranteed via third-party high-performance liquid chromatography testing.

Storage Compliance

Stored at -20°C in oxygen-free environment. Shipped with cold-chain monitoring protocols.

CAS Registry

Uniquely identified compound with full structural validation and mass spectrometry reports.

Usage Policy

Strictly for lab research. Not for human or therapeutic use. Waiver required for bulk orders.